The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
CXCR4 over-expression and survival in cancer: A system review and meta-analysis
Open accessAbstract
// Hongli Zhao 1,* , Liyuan Guo 2,* , Hong Zhao 1,* , Jiaxin Zhao 3 , Hao Weng 4 and Bin Zhao 5 1 Department of Medical Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin, China 2 Department of Gynecological Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin, China 3 Department of Neurosurgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China 4 Shanghai Jiaotong University Affiliated Sixth People’s Hospital South Campus, Shanghai, China 5 Harbin Medical University, Daqing Campus, China * Authors contributed equally to this work and were co-first authors Correspondence: Bin Zhao, email: // Keywords : CXCR4, cancer, survival, prognostic biomarker, meta-analysis Received : November 23, 2014 Accepted : December 28, 2014 Published : December 31, 2014 Abstract C-X-C chemokine receptor 4 (CXCR4) is frequently over-expressed in various types of cancer; many agents against CXCR4 are in clinical development currently despite variable data for the prognostic impact of CXCR4 expression. Here eighty-five studies with a total of 11,032 subjects were included to explore the association between CXCR4 and progression-free survival (PFS) or overall survival (OS) in subjects with cancer. Pooled analysis shows that CXCR4 over-expression is significantly associated with poorer PFS (HR 2.04; 95% CI, 1.72-2.42) and OS (HR=1.94; 95% CI, 1.71-2.20) irrespective of cancer types. Subgroup analysis indicates significant association between CXCR4 and shorter PFS in hematological malignancy, breast cancer, colorectal cancer, esophageal cancer, renal cancer, gynecologic cancer, pancreatic cancer and liver cancer; the prognostic effects remained consistent across age, risk of bias, levels of adjustment, median follow-up period, geographical area, detection methods, publication year and size of studies. CXCR4 over-expression predicts unfavorable OS in hematological malignancy, breast cancer, colorectal cancer, esophageal cancer, head and neck cancer, renal cancer, lung cancer, gynecologic cancer, liver cancer, prostate cancer and gallbladder cancer; these effects were independence of age, levels of adjustment, publication year, detection methods and follow-up period. In conclusion, CXCR4 over-expression is associated with poor prognosis in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Practical methods for incorporating summary time-to-event data into meta-analysis.
Tierney, J. F., Stewart, L. A., Ghersi, D., Burdett, S., & Sydes, M. R. (2007) · Trials · doi:10.1186/1745-6215-8-16 · Cited by 6,208
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Cytokine patterns in patients with cancer: a systematic review
Lippitz, B. E. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70582-x · Cited by 905
CXCR4–SDF-1 Signalling, Locomotion, Chemotaxis and Adhesion
Kucia, M., Jankowski, K., Reca, R., Wysoczynski, M., Bandura, L., Allendorf, D. J., Zhang, J., Ratajczak, J., & Ratajczak, M. Z. (2004) · Journal of Molecular Histology · doi:10.1023/b:hijo.0000032355.66152.b8 · Cited by 698
A review on CXCR4/CXCL12 axis in oncology: No place to hide
Domanska, U. M., Kruizinga, R. C., Nagengast, W. B., Timmer-Bosscha, H., Huls, G., de Vries, E. G. E., & Walenkamp, A. M. E. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.05.005 · Cited by 635
Kim, J., Takeuchi, H., Lam, S. T., Turner, R. R., Wang, H.-J., Kuo, C., Foshag, L., Bilchik, A. J., & Hoon, D. S. B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.078 · Cited by 378
CXCR4 is a prognostic marker in acute myelogenous leukemia
Spoo, A. C., Lübbert, M., Wierda, W. G., & Burger, J. A. (2007) · Blood · doi:10.1182/blood-2006-05-024844 · Cited by 330
Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma
Scala, S., Ottaiano, A., Ascierto, P. A., Cavalli, M., Simeone, E., Giuliano, P., Napolitano, M., Franco, R., Botti, G., & Castello, G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1887 · Cited by 280
Small Molecule Inhibitors of CXCR4
Debnath, B., Xu, S., Grande, F., Garofalo, A., & Neamati, N. (2013) · Theranostics · doi:10.7150/thno.5376 · Cited by 273
Rombouts, E. J. C., Pavic, B., Löwenberg, B., & Ploemacher, R. E. (2004) · Blood · doi:10.1182/blood-2004-02-0566 · Cited by 272
The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study
Salvucci, O., Bouchard, A., Baccarelli, A., Deschenes, J., Sauter, G., Simon, R., Bianchi, R., & Basik, M. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9121-8 · Cited by 221
Tumor-Cell Homing to Lymph Nodes and Bone Marrow and CXCR4 Expression in Esophageal Cancer
Kaifi, J. T., Yekebas, E. F., Schurr, P., Obonyo, D., Wachowiak, R., Busch, P., Heinecke, A., Pantel, K., & Izbicki, J. R. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji431 · Cited by 217
Spano, J.-P., Andre, F., Morat, L., Sabatier, L., Besse, B., Combadiere, C., Deterre, P., Martin, A., Azorin, J., Valeyre, D., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh136 · Cited by 211
Andre, F., Cabioglu, N., Assi, H., Sabourin, J. C., Delaloge, S., Sahin, A., Broglio, K., Spano, J. P., Combadiere, C., Bucana, C., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl053 · Cited by 190
Translating an Antagonist of Chemokine Receptor CXCR4: From Bench to Bedside
Wong, D., & Korz, W. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4846 · Cited by 186
CXC Chemokine Receptor 4 Is a Cell Surface Receptor for Extracellular Ubiquitin
Saini, V., Marchese, A., & Majetschak, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.103408 · Cited by 179
Jiang, Y.-P., Wu, X.-H., Shi, B., Wu, W.-X., & Yin, G.-R. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.02.036 · Cited by 173
High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
Maréchal, R., Demetter, P., Nagy, N., Berton, A., Decaestecker, C., Polus, M., Closset, J., Devière, J., Salmon, I., & Van Laethem, J.-L. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605020 · Cited by 173
Ottaiano, A., Franco, R., Aiello Talamanca, A., Liguori, G., Tatangelo, F., Delrio, P., Nasti, G., Barletta, E., Facchini, G., Daniele, B., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2142 · Cited by 171
Konoplev, S. N., Rassidakis, G. Z., Estey, E. H., Kantarjian, H. M., Liakou, C. I., Huang, X., Xiao, L., Andreeff, M., Konopleva, M. Y., & Medeiros, L. J. (2007) · Cancer · doi:10.1002/cncr.22510 · Cited by 160
Cabıoğlu, N., Gong, Y. Y., Islam, R., Broglio, K. R., Sneige, N., Şahin, A. A., Gonzalez-Angulo, A. M., Morandi, P., BUCANA, C. D., Hortobágyi, G. N., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm060 · Cited by 151
New insights on the role of CXCR4 in cancer metastasis
Zlotnik, A. (2008) · The Journal of Pathology · doi:10.1002/path.2350 · Cited by 140
Kodama, J., Hasengaowa, Kusumoto, T., Seki, N., Matsuo, T., Ojima, Y., Nakamura, K., Hongo, A., & Hiramatsu, Y. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl342 · Cited by 135
Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis
Zhang, Z., Ni, C., Chen, W., Wu, P., Wang, Z., Yin, J., Huang, J., & Qiu, F. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-49 · Cited by 129
Genomic organization and promoter characterization of human CXCR4 gene1
Carúz, A., Samsom, M., Alonso, J. M., Alcamı́, J., Baleux, F., Virelizier, J. L., Parmentier, M., & Arenzana‐Seisdedos, F. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00359-7 · Cited by 116
The chemokine, CXCL12, is an independent predictor of poor survival in ovarian cancer
Popple, A. L., Durrant, L. G., Spendlove, I., Rolland, P. D., Scott, I., Deen, S., & Ramage, J. M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.49 · Cited by 115
CXCL12 and CXCR4 in adenocarcinoma of the lung: Association with metastasis and survival
Wagner, P. L., Hyjek, E. M., Vazquez, M., Meherally, D., Liu, Y. F., Chadwick, P. A., Rengifo, T. P., Sica, G., Port, J. L., Lee, P. C., et al. (2008) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2008.07.039 · Cited by 111
Mirisola, V., Zuccarino, A., Bachmeier, B. E., Sormani, M. P., Falter, J., Nerlich, M. L., & Pfeffer, U. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.06.026 · Cited by 107
Xiang, Z., Zeng, Z., Tang, Z., Fan, J., Zhuang, P., Liang, Y. J., Tan, Y.-S., & He, J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-176 · Cited by 97
Pils, D., Pinter, A., Reibenwein, J., Alfanz, A., Horak, P., Schmid, B. C., Hefler, L., Horvat, R., Reinthaller, A., Zeillinger, R., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603581 · Cited by 90
Expression of CXCR4 and Its Down-Regulation by IFN-γ in Head and Neck Squamous Cell Carcinoma
Katayama, A., Ogino, T., Bandoh, N., Nonaka, S., & Harabuchi, Y. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1470 · Cited by 84
Clinical significance of CXCR3 and CXCR4 expression in primary melanoma
Longo-Imedio, M. I., Longo, N., Treviño, I., Lázaro, P., & Sánchez‐Mateos, P. (2005) · International Journal of Cancer · doi:10.1002/ijc.21269 · Cited by 80
Otsuka, S., Klimowicz, A. C., Kopciuk, K. A., Petrillo, S. K., Konno, M., Hao, D., Muzik, H., Stolte, E., Boland, W. K., Morris, D. G., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182199a99 · Cited by 75
Oda, Y., Ohishi, Y., Basaki, Y., Kobayashi, H., Hirakawa, T., Wake, N., Ono, M., Nishio, K., Kuwano, M., & Tsuneyoshi, M. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00492.x · Cited by 71
The Prognostic Value of CXCR4 in Ovarian Cancer: A Meta-Analysis
Liu, C., Liu, S.-Y., Min, X.-Y., Ji, Y., Wang, N., Liu, D., Ma, N., Li, Z., & Li, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092629 · Cited by 69
Fanelli, M. F., Chinen, L. T. D., Begnami, M. D., da Costa, W. L., Fregnami, J. H. T., Soares, F. A., & MONTAGNINI, A. L. (2012) · Histopathology · doi:10.1111/j.1365-2559.2011.04139.x · Cited by 68
Li, J., Jiang, K., Qiu, X., Li, M., Hao, Q., Li, W., Zhang, W., Chen, B., & Xin, X. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.1.069 · Cited by 63
Wang, N., Wu, Q., Fang, Y., Mai, H., Zeng, M., Shen, G., Hou, J., & Zeng, Y. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-26 · Cited by 60
Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma
Gockel, I., Schimanski, C. C., Heinrich, C., Wehler, T., Frerichs, K., Drescher, D. G., von Langsdorff, C., Domeyer, M., Biesterfeld, S., Galle, P. R., et al. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-290 · Cited by 58
Low expression of MicroRNA‐126 is associated with poor prognosis in colorectal cancer
Liu, Y., Zhou, Y., Feng, X., Yang, P., Yang, J., An, P., Wang, H., Ye, S., Yu, C., He, Y., et al. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22146 · Cited by 55
Saigusa, S., Toiyama, Y., Tanaka, K., Yokoe, T., Okugawa, Y., Kawamoto, A., Yasuda, H., Inoue, Y., Miki, C., & Kusunoki, M. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0970-y · Cited by 53
Lin, F., Zheng, S.-E., Shen, Z., Tang, L., Chen, P., Sun, Y., Zhao, H., & Yao, Y. (2010) · Medical Oncology · doi:10.1007/s12032-010-9493-4 · Cited by 50
Self-citationThe Prognostic Value of CXCR4 in Acute Myeloid Leukemia
Ahn, J. Y., Seo, K., Weinberg, O. K., & Arber, D. A. (2012) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e3182606f4d · Cited by 50
Chen, D., Gassenmaier, M., Maruschke, M., Riesenberg, R., Pohla, H., Stief, C. G., Zimmermann, W., & Büchner, A. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.08.052 · Cited by 50
Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma
Gebauer, F., Tachezy, M., Effenberger, K. E., von Loga, K., Zander, H., Marx, A., Kaifi, J. T., Sauter, G., Izbicki, J. R., & Bockhorn, M. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.21957 · Cited by 50
Zhang, L., Ye, S., Ma, G., Tang, X.-F., Chen, S.-P., He, J., Liu, W.-L., Xie, D., Zeng, Y.-X., & Li, J. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-60 · Cited by 49
He, H., Wang, C., Shen, Z., Fang, Y., Wang, X., Chen, W., Liu, F., Qin, X., & Sun, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071864 · Cited by 41
Oda, Y., Tateishi, N., Matono, H., Matsuura, S., Yamamaoto, H., Tamiya, S., Yokoyama, R., Matsuda, S., Iwamoto, Y., & Tsuneyoshi, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.24128 · Cited by 39
Expression of Chemokine Receptors in Human Gastric Cancer
Kwak, M. K., Hur, K., Park, D. J., Lee, H.-J., Lee, H. S., Kim, W. H., Lee, K. U., Choe, K. J., & Yang, H.-K. (2005) · Tumor Biology · doi:10.1159/000085587 · Cited by 39
CXCR4 is a good survival prognostic indicator in multiple myeloma patients
Bao, L., Lai, Y., Liu, Y., Qin, Y.-Z., Zhao, X., Lu, X.-J., Jiang, Q., Lu, J., & Huang, X. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.06.002 · Cited by 39
Wang, M., Chen, G., Song, H., Hong, X., Yang, Z., & Sui, G. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.235 · Cited by 38
Oda (2009) · Oncology Reports · doi:10.3892/or_00000341 · Cited by 36
Reckamp, K. L., Figlin, R. A., Burdick, M. D., Dubinett, S. M., Elashoff, R. M., & Strieter, R. M. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-213 · Cited by 35
Lü, C., Ji, Y., Ge, D., Guo, J., & Ding, J. (2010) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2010.01135.x · Cited by 34
Albert, S., Hourseau, M., Halimi, C., Serova, M., Descatoire, V., Barry, B., Couvelard, A., Riveiro, M. E., Tijeras‐Raballand, A., Gramont, A. D. E., et al. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.06.010 · Cited by 32
Hiller, D. J., Meschonat, C., Kim, R. H., Li, B. D. �., & Chu, Q. D. (2011) · Surgery · doi:10.1016/j.surg.2011.07.005 · Cited by 30
An, H., Xu, L., Zhu, Y., Lv, T., Liu, W., Liu, Y., Liu, H., Chen, L., Xu, J., & Lin, Z. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.179 · Cited by 24
Yu, S., Wang, X., Liu, G., et al. (2013) · PubMed · doi:10.18926/amo/52010 · Cited by 19
Konoplev, S. N., Lin, P., Yin, C. C., Lin, E., Nogueras‐González, G. M., Kantarjian, H. M., Andreeff, M., Medeiros, L. J., & Konopleva, M. Y. (2013) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2013.05.013 · Cited by 17
The molecular and clinicopathologic characteristics of bilateral breast cancer
Chen, S., Du, C., Yang, P., Zhang, H. W., Kwan, M. L., & Zhang, G. J. (2013) · Scientific Reports · doi:10.1038/srep02590 · Cited by 14
Li, X., Huang, Y., Xia, J., Chen, N., Wei, Q., Li, X., Zhang, P., Shen, P., Wang, J., & Zeng, H. (2011) · PubMed · Cited by 12
Cited by
CXCR4 signaling in health and disease
Pozzobon, T., Goldoni, G., Viola, A., & Molon, B. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.06.006 · Cited by 256
Bhattarai, S., Mackeyev, Y., Venkatesulu, B. P., Krishnan, S., & Singh, P. K. (2021) · Nanoscale · doi:10.1039/d1nr05385j · Cited by 22
Metadata
- Authors
- Zhao, H., Guo, L., Zhao, H., Zhao, J., Weng, H., & Zhao, B.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2014-12-31
- Volume
- 6
- Issue
- 7
- Pages
- 5022-5040
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1511246213
- Cited by
- 274
- References
- 68
- FWCI
- 8.04
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.